This page collects WhisperX intelligence signals tagged #deal_flow. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Biogen has made a decisive $5.6 billion move to acquire Apellis Pharmaceuticals, marking one of its largest-ever acquisitions. The deal is a strategic pivot to significantly expand Biogen's portfolio in immunology and rare disease treatments, signaling a major investment in a high-value therapeutic area. This acquisiti...
Eli Lilly is reportedly moving to acquire the cancer-focused biotech firm CrossBridge Bio in a deal valued at up to $300 million, a strategic move to bolster its oncology portfolio. The purported acquisition, discussed by Portal Innovations CEO John Flavin on Bloomberg's "The Close," signals a targeted investment in a ...